- Home
- KTTA vs NAOV Comparison
KTTA vs NAOV Comparison
Compare KTTA & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- NAOV
- Stock Information
- Founded
- KTTA 2020
- NAOV 2003
- Country
- KTTA United States
- NAOV United States
- Employees
- KTTA N/A
- NAOV N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- NAOV Industrial Specialties
- Sector
- KTTA Health Care
- NAOV Health Care
- Exchange
- KTTA Nasdaq
- NAOV Nasdaq
- Market Cap
- KTTA 2.8M
- NAOV 2.4M
- IPO Year
- KTTA 2021
- NAOV N/A
- Fundamental
- Price
- KTTA $0.73
- NAOV $1.13
- Analyst Decision
- KTTA
- NAOV
- Analyst Count
- KTTA 0
- NAOV 0
- Target Price
- KTTA N/A
- NAOV N/A
- AVG Volume (30 Days)
- KTTA 222.0K
- NAOV 8.3M
- Earning Date
- KTTA 08-12-2025
- NAOV 08-13-2025
- Dividend Yield
- KTTA N/A
- NAOV N/A
- EPS Growth
- KTTA N/A
- NAOV N/A
- EPS
- KTTA N/A
- NAOV N/A
- Revenue
- KTTA N/A
- NAOV $2,662,000.00
- Revenue This Year
- KTTA N/A
- NAOV N/A
- Revenue Next Year
- KTTA N/A
- NAOV N/A
- P/E Ratio
- KTTA N/A
- NAOV N/A
- Revenue Growth
- KTTA N/A
- NAOV N/A
- 52 Week Low
- KTTA $0.71
- NAOV $0.67
- 52 Week High
- KTTA $7.50
- NAOV $16.25
- Technical
- Relative Strength Index (RSI)
- KTTA 33.06
- NAOV 34.30
- Support Level
- KTTA $0.71
- NAOV $0.88
- Resistance Level
- KTTA $0.80
- NAOV $0.94
- Average True Range (ATR)
- KTTA 0.04
- NAOV 0.12
- MACD
- KTTA 0.00
- NAOV 0.11
- Stochastic Oscillator
- KTTA 12.14
- NAOV 7.06
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.